EUVIMEDEUVIMED entdecken
Crossref

Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling

Anming Zhu, Junxi Liu, Xianxian Cao, Jiahui Wu, Fengkun Xiao, Youyun Liu, Yanzhen Shen, Feifei Wang, Liping Qu

International Immunopharmacology · 2026-12 · 190 · 117489

DOI: 10.1016/j.intimp.2026.117489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Anming Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Characteristic Plant Extraction Laboratory, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming 650106, China; Yunnan Botanee…. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Anti-Inflammatory Agents. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cheilitis is a lip-specific inflammatory disorder lacking safe long-term therapies. Topical glucocorticoids are limited by adverse effects, highlighting the need for plant-derived immunomodulators with dual anti-inflammatory and barrier-repairing effects. OBJECTIVE: To evaluate the therapeutic potential, mechanism and human efficacy of pedunculoside in cheilitis. METHODS: Pedunculoside was evaluated in vitro using CCK-8, scratch, ELISA, immunofluorescence, RT-qPCR, western blot, molecular docking and SPR. In human efficacy evaluation, pedunculoside formulation were assessed by VISIA-CR imaging, skin hydration and transepidermal water loss on the lips. RESULTS: Pedunculoside (≤120 μM) showed no cytotoxicity and increased scratch wound closure 4.5-fold (N = 4). It upregulated barrier genes (AQP3: 1.7-fold, FLG: 2.3-fold, SPINK5: 11.16-fold, IVL: 7.96-fold, ZO-1: 2.26-fold, OCLN: 2.22-fold and KRT1: 4.41-fold) (N = 4) and suppressed inflammatory cytokines (IL-6: 0.68-fold, IL-8: 0.53-fold, IL-1β: 0.65-fold, TSLP: 0.69-fold, CCL5: 0.55-fold and CCL17: 0.58-fold) (N = 3). Mechanistically, pedunculoside directly bound with TLR3 and suppressed TLR3/TRIF/NF-κB signaling. In human efficacy, the pedunculoside formulation reduced lip redness by 0.3-fold (4 h, N = 32) and 0.23-fold (at 28 days, N = 20), decreased TEWL value by 0.22-fold (at 4 h) and 0.27-fold (at 28 days) and improved hydration by 0.22-fold (at 4 h) and 0.27-fold (at 28 days) versus baseline. CONCLUSION: Pedunculoside is a novel TLR3-targeting immunomodulator that enhances barrier repair and suppresses inflammation in vitro, while its formulation improves cheilitis symptoms. The absence of animal studies before human testing represents a limitation; larger trials are warranted to confirm long-term safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 3Anti-Inflammatory AgentsHumansSignal TransductionNF-kappa BAdaptor Proteins, Vesicular TransportInflammationAnimalsCytokines

Stichwörter der Autor:innen

Barrier repairCheilitisInflammationPedunculosideTLR3/TRIF/NF-κB

Substanzen

Toll-Like Receptor 3NF-kappa BAnti-Inflammatory AgentsAdaptor Proteins, Vesicular TransportTICAM1 protein, humanTLR3 protein, humanCytokines

Autor:innen und Institutionen

  • Yunnan Characteristic Plant Extraction Laboratory, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming 650106, China; Yunnan Botanee Bio-Technology Group Co., Ltd., Kunming 650106, China; Botanee Resear…
  • Yunnan Botanee Bio-Technology Group Co., Ltd., Kunming 650106, China; Botanee Research Institute, Shanghai Jiyan Biomedical Development Co., Ltd, Shanghai 201702, China.
  • Yunnan Characteristic Plant Extraction Laboratory, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming 650106, China; Botanee Research Institute, Shanghai Jiyan Biomedical Development Co., Ltd, Shanghai…
  • Yunnan Characteristic Plant Extraction Laboratory, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Kunming 650106, China; Yunnan Botanee Bio-Technology Group Co., Ltd., Kunming 650106, China.

Zitieren

APA

Zhu, A., Liu, J., Cao, X., Wu, J., Xiao, F., Liu, Y., Shen, Y., Wang, F., & Qu, L. (2026). Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling. International Immunopharmacology, 190, 117489. https://doi.org/10.1016/j.intimp.2026.117489

Vancouver

Zhu A, Liu J, Cao X, Wu J, Xiao F, Liu Y, et al. Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling. International Immunopharmacology. 2026;190:117489. doi:10.1016/j.intimp.2026.117489

BibTeX
@article{Zhu2026,
  author = {Zhu, Anming and Liu, Junxi and Cao, Xianxian and Wu, Jiahui and Xiao, Fengkun and Liu, Youyun and Shen, Yanzhen and Wang, Feifei and Qu, Liping},
  title = {Pedunculoside alleviates cheilitis-like inflammation by suppressing the TLR3/TRIF/NF-κB signaling},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {190},
  pages = {117489},
  doi = {10.1016/j.intimp.2026.117489}
}
Kostenlos starten →